These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 7742466)
21. Viridans streptococcal bacteremia-related encephalopathy in childhood with malignancy. Sato Y; Okuya M; Hagisawa S; Matsushita T; Fukushima K; Kurosawa H; Sugita K; Arisaka O Pediatr Hematol Oncol; 2011 Feb; 28(1):24-30. PubMed ID: 21247349 [TBL] [Abstract][Full Text] [Related]
22. Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients. Gassas A; Grant R; Richardson S; Dupuis LL; Doyle J; Allen U; Abla O; Sung L J Clin Oncol; 2004 Apr; 22(7):1222-7. PubMed ID: 15051769 [TBL] [Abstract][Full Text] [Related]
24. Group A beta-hemolytic streptococcal bacteremia: historical overview, changing incidence, and recent association with varicella. Doctor A; Harper MB; Fleisher GR Pediatrics; 1995 Sep; 96(3 Pt 1):428-33. PubMed ID: 7651773 [TBL] [Abstract][Full Text] [Related]
25. Bacteremia due to oral viridans streptococci in neutropenic patients with cancer: cytostatics are a more important risk factor than antibacterial prophylaxis. Donnelly JP; Dompeling EC; Meis JF; de Pauw BE Clin Infect Dis; 1995 Feb; 20(2):469-70. PubMed ID: 7742460 [No Abstract] [Full Text] [Related]
26. Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases. Kern W; Kurrle E; Schmeiser T Infection; 1990; 18(3):138-45. PubMed ID: 2365465 [TBL] [Abstract][Full Text] [Related]
27. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Ruescher TJ; Sodeifi A; Scrivani SJ; Kaban LB; Sonis ST Cancer; 1998 Jun; 82(11):2275-81. PubMed ID: 9610710 [TBL] [Abstract][Full Text] [Related]
28. Stimulation of cytokine release and adhesion molecule expression by products of Viridans streptococci. Hanage WP; Cohen J J Infect Dis; 2002 Feb; 185(3):357-67. PubMed ID: 11807718 [TBL] [Abstract][Full Text] [Related]
29. Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure. Stevens DL; Bryant AE; Hackett SP; Chang A; Peer G; Kosanke S; Emerson T; Hinshaw L J Infect Dis; 1996 Mar; 173(3):619-26. PubMed ID: 8627025 [TBL] [Abstract][Full Text] [Related]
30. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients. Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857 [TBL] [Abstract][Full Text] [Related]
31. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Bochud PY; Eggiman P; Calandra T; Van Melle G; Saghafi L; Francioli P Clin Infect Dis; 1994 Jan; 18(1):25-31. PubMed ID: 8054434 [TBL] [Abstract][Full Text] [Related]
33. Comparison of clinical characteristics of group A streptococcal bacteremia in children and adults. Begovac J; Kuzmanović N; Bejuk D Clin Infect Dis; 1996 Jul; 23(1):97-100. PubMed ID: 8816136 [TBL] [Abstract][Full Text] [Related]
35. Complications of bacteremia due to Stomatococcus mucilaginosus in neutropenic children. Henwick S; Koehler M; Patrick CC Clin Infect Dis; 1993 Oct; 17(4):667-71. PubMed ID: 8268348 [TBL] [Abstract][Full Text] [Related]
36. High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients. Marron A; Carratalà J; Alcaide F; Fernández-Sevilla A; Gudiol F J Antimicrob Chemother; 2001 Jan; 47(1):87-91. PubMed ID: 11152436 [TBL] [Abstract][Full Text] [Related]
37. Viridans streptococci bacteraemia in children with fever and neutropenia: a case-control study of predisposing factors. Paganini H; Staffolani V; Zubizarreta P; Casimir L; Lopardo H; Luppino V Eur J Cancer; 2003 Jun; 39(9):1284-9. PubMed ID: 12763218 [TBL] [Abstract][Full Text] [Related]
38. Bacteremia in cancer patients with solid tumors undergoing chemotherapy versus surgery: risk factors, etiology and outcome in 276 patients. Krcmery V; Spanik S; Stopkova K; Grausova S; Mardiak J; Koren P; Sepesi J; Pechan J; Demitrovicová A; Kralovicová K; Novotny J J Chemother; 1997 Jun; 9(3):232-7. PubMed ID: 9210008 [TBL] [Abstract][Full Text] [Related]
39. Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation. Broun ER; Wheat JL; Kneebone PH; Sundblad K; Hromas RA; Tricot G Antimicrob Agents Chemother; 1994 Mar; 38(3):576-9. PubMed ID: 8203857 [TBL] [Abstract][Full Text] [Related]
40. Early gram-positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis. Arns da Cunha C; Weisdorf D; Shu XO; DeFor T; Pastor JD; Johnson JR Bone Marrow Transplant; 1998 Jan; 21(2):173-80. PubMed ID: 9489635 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]